Safety of 18F-DOPA injection for PET of carcinoid tumor [3]

Journal of Nuclear Medicine

Volumn 47, Issue 10, 2006, Pages 1732-

  Nataf, Valérie ^a   Balard, Macha ^a   De Beco, Virginie ^a   Kerrou, Khaldoun ^a   Gutman, Fabrice ^a   Grahek, Dany ^a   Montravers, Françoise ^a   Talbot, Jean Noël ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; CARBIDOPA; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; FLUORINE; FLUORODOPA F 18; RADIOPHARMACEUTICAL AGENT;

BURNING SENSATION; CANCER DIAGNOSIS; CARCINOID; DIAGNOSTIC IMAGING; DRUG METABOLISM; DRUG SAFETY; HUMAN; LETTER; NEUROENDOCRINE TUMOR; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; CARCINOID SYNDROME; CHEMICALLY INDUCED DISORDER; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; NOTE; SCINTISCANNING;

CARCINOID TUMOR; DIHYDROXYPHENYLALANINE; FLUORINE RADIOISOTOPES; HUMANS; INJECTIONS, INTRAVENOUS; MALIGNANT CARCINOID SYNDROME; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 34247626311     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (1)

1. 18F-fluorodihydroxyphenyalanine in a patient with metastatic carcinoid. J Nucl Med. 2005;46:1240-1243.